1. Home
  2. RGEN vs LSCC Comparison

RGEN vs LSCC Comparison

Compare RGEN & LSCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • LSCC
  • Stock Information
  • Founded
  • RGEN 1981
  • LSCC 1983
  • Country
  • RGEN United States
  • LSCC United States
  • Employees
  • RGEN N/A
  • LSCC N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • LSCC Semiconductors
  • Sector
  • RGEN Health Care
  • LSCC Technology
  • Exchange
  • RGEN Nasdaq
  • LSCC Nasdaq
  • Market Cap
  • RGEN 8.0B
  • LSCC 6.8B
  • IPO Year
  • RGEN N/A
  • LSCC 1989
  • Fundamental
  • Price
  • RGEN $120.21
  • LSCC $46.54
  • Analyst Decision
  • RGEN Buy
  • LSCC Strong Buy
  • Analyst Count
  • RGEN 12
  • LSCC 12
  • Target Price
  • RGEN $172.67
  • LSCC $63.58
  • AVG Volume (30 Days)
  • RGEN 811.4K
  • LSCC 2.9M
  • Earning Date
  • RGEN 04-29-2025
  • LSCC 05-05-2025
  • Dividend Yield
  • RGEN N/A
  • LSCC N/A
  • EPS Growth
  • RGEN N/A
  • LSCC N/A
  • EPS
  • RGEN N/A
  • LSCC 0.37
  • Revenue
  • RGEN $650,429,000.00
  • LSCC $488,736,000.00
  • Revenue This Year
  • RGEN $13.93
  • LSCC $3.39
  • Revenue Next Year
  • RGEN $14.35
  • LSCC $18.55
  • P/E Ratio
  • RGEN N/A
  • LSCC $125.80
  • Revenue Growth
  • RGEN 4.88
  • LSCC N/A
  • 52 Week Low
  • RGEN $102.97
  • LSCC $34.69
  • 52 Week High
  • RGEN $182.52
  • LSCC $78.29
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 39.75
  • LSCC 41.93
  • Support Level
  • RGEN $120.11
  • LSCC $45.17
  • Resistance Level
  • RGEN $129.42
  • LSCC $57.23
  • Average True Range (ATR)
  • RGEN 6.22
  • LSCC 2.40
  • MACD
  • RGEN -0.97
  • LSCC -0.16
  • Stochastic Oscillator
  • RGEN 0.43
  • LSCC 11.36

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

Share on Social Networks: